tanshinone has been researched along with ovalbumin in 2 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, S; Li, S; Li, Z; Tan, T; Wu, Y; Xu, F | 1 |
| Chen, H; Chen, Q; Dai, M; Li, Y; Liu, H; Shao, L; Xiang, N | 1 |
2 other study(ies) available for tanshinone and ovalbumin
| Article | Year |
|---|---|
Tanshinone IIA improves degranulation of mast cells and allergic rhinitis induced by ovalbumin by inhibiting the PLCĪ³1/PKC/IP3R pathway.
Topics: Abietanes; Animals; Cell Degranulation; Cell Line; Disease Models, Animal; Mast Cells; Mice; Ovalbumin; Phospholipase C gamma; Protein Kinase C; Rhinitis, Allergic | 2021 |
Tanshinone IIA alleviates ovalbumin-induced allergic rhinitis symptoms by inhibiting Th2 cytokine production and mast cell histamine release in mice.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; Cytokines; Dexamethasone; Disease Models, Animal; Histamine Release; Male; Mast Cells; Mice; Mice, Inbred BALB C; Ovalbumin; Rhinitis, Allergic; Th2 Cells | 2022 |